Fujirebio

@fujirebio.com

Fujirebio is a global leader in the field of high-quality in vitro diagnostics (IVD). We are an R&D-driven company constantly developing new technologies and unique biomarkers with high clinical value.

🌟 Breaking news: Fujirebio receives US FDA marketing clearance for Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic test as an aid to identify patients with amyloid pathology associated with Alzheimer's disease. Our full press release is here 👉 www.fujirebio.com/en/news-even...

Bild

Understanding Disease Through #Biomarkers Join us on May 20th for a LIVE #symposium and discover how scientists are revolutionizing the identification and characterization of biomarkers for #cancer, #neurodegenerative diseases, and #autoimmune disorders. 👉 Reserve your spot now! lnkd.in/eHqJ9Say

Understanding Disease Through Biomarkers

Learn how scientists identify and characterize biomarkers for cancer, neurodegenerative diseases, and autoimmune disorders.

the-scientist.com